Format

Send to

Choose Destination
New Microbiol. 2017 Apr;40(2):86-98.

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016.

Author information

1
National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy.
2
IRCCS AOU San Martino Hospital, Genova, Italy.
3
Nadir Onlus, Rome, Italy.
4
University of Tor Vergata, Rome, Italy.
5
P.O. Cotugno, AORN Ospedali dei Colli, Naples, Italy.
6
University of Milan, Milan, Italy.
7
S.M. Annunziata Hospital, Florence, Italy.
8
University of Modena and Reggio Emilia, Modena, Italy.
9
Niguarda Hospital, Milan, Italy.
10
San Raffaele Scientific Institute, Milan, Italy.

Abstract

The Italian Society of Infectious and Tropical Diseases (SIMIT) of the Technical Health Committee, Ministry of Health (Sections L and M) of Italy have supported recommendations for the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. This publication summarizes the latest updates to the 2016 version of the Italian Guidelines for the management of HIV-1 infected patients and the use of antiretroviral drugs. In particular, new recommendations were released concerning the following topics: estimate of the HIV continuum of care in Italy, optimal timing and preferred drug combinations for starting antiretroviral therapy, treatment optimization, and pre-exposure prophilaxis (PrEP). For a complete review of clinical and therapeutic relevant topics we refer the reader to the extended version of the Guidelines.

KEYWORDS:

Guidelines; HIV; Italy; antiretroviral agents

PMID:
28513816
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Italian Society for Medical, Odontoiatric, and Clinical Microbiology
Loading ...
Support Center